Managing recurrence following bladder-sparing treatment
"If there’s recurrence of muscle-invasive bladder cancer within the bladder, you can perform salvage cystectomy at that point…. It is a bit more complex, so it’s great to have a high-volume surgeon who has performed these before," says Sophia C. Kamran, MD.
In this video, Sophia C. Kamran, MD, discusses management of recurrence following bladder-sparing treatment. Kamran is a radiation oncologist at the Massachusetts General Hospital Cancer Center and Assistant Professor of Radiation Oncology at Harvard Medical School, Boston, Massachusetts.
Transcription:
How are relapses or recurrences managed?
It really…depends on the recurrence, and the type of recurrence. We follow patients very closely after treatment with either radical cystectomy or bladder-sparing therapy. If a patient develops a metastatic lesion, or if they develop metastases, then really chemotherapy or immunotherapy, just depending on the…clinical scenario, you’d want something systemic to go everywhere. If there is a superficial recurrence within the bladder, these are managed urologically with either the scraping procedure (TURBT; transurethral resection of bladder tumor) or some type of intravesical therapy. If there’s recurrence of muscle-invasive bladder cancer within the bladder, you can perform salvage cystectomy at that point…. It is a bit more complex, so it’s great to have a high-volume surgeon who has performed these before.
This transcript was edited for clarity.
Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app
December 7th 2021“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
